Get the Meet Midlife Edit

Guides · Appointments

How to talk to your doctor about menopause

You finally got the appointment. Then the door closes, the clock starts, and half of what you meant to say evaporates. Here's how to walk in prepared and walk out with a plan, plus a checklist you can print.

5 min readUpdated Oct 2026Evidence-checked · sources listed

Information for better conversations, not a diagnosis. This is research with sources, not medical advice. Talk to your clinician about your situation.

Why preparing pays off

Many clinicians get surprisingly little menopause training. In a 2017 survey of 183 family medicine, internal medicine and OB-GYN residents in the US, only 6.8% said they felt adequately prepared to manage women going through menopause, and 20.3% said they'd had no menopause lectures during residency. Only about a quarter of residents who were sent the survey answered it, so treat the numbers as a snapshot.1

That's not a reason to distrust your clinician. It's a reason to arrive organized, so the visit is spent on you and not on reconstructing the last six months from memory.

Before you go

  • Track for two weeks. Fill in our printable tracker each evening: periods, hot flashes, sleep, mood, brain fog, joint aches and more.
  • Make a list and put it in order. The National Institute on Aging suggests listing what you want to discuss and raising the most important items first, not saving them for the end.2
  • Bring your medicines. Bring all your prescriptions, over-the-counter medicines, vitamins and supplements in a bag, or a list with doses. Bring your insurance cards and the names of other doctors you see.2
  • Consider bringing someone. A friend or family member can take notes and remind you what you meant to ask. You can still ask for time alone with the doctor for private topics.2

What to say

Be specific and lead with impact: not "I'm tired," but "I'm waking three times a night soaked, and I nearly fell asleep driving." Then cover the basics.

  • Your periods. ACOG says changes in bleeding are normal in perimenopause, but you should still report them, because abnormal bleeding can be a sign of a problem.3 Bleeding after menopause is considered abnormal and should be checked.4
  • Your symptoms. ACOG lists hot flashes, night sweats, sleep problems, and vaginal and urinary changes among the common signs of perimenopause.3 Mention mood, memory and joint changes too. They count.
  • Your history. The Menopause Society lists unexplained vaginal bleeding, liver disease, breast or other estrogen-sensitive cancer, past heart disease, stroke or blood clots, and a high inherited risk of clots as reasons hormone therapy may not be safe.5 Mention your family history too, so your clinician has the full picture.

Do I need a hormone test?

Often, no. The UK's National Institute for Health and Care Excellence (NICE) guideline says that for otherwise healthy people aged 45 or over with menopause symptoms, perimenopause and menopause can be identified from symptoms and periods without lab tests.6 It recommends considering an FSH blood test to confirm menopause only for people aged 40 to 45 with symptoms, or under 40 when menopause is suspected.6 NICE is a UK body, and US clinicians may follow different practices, so ask what applies to you and why. Tests to rule out other causes are a different matter.

If you're under 45

Symptoms before 45, and especially before 40, are worth raising promptly. The Menopause Society notes that losing ovarian function early (premature menopause before 40, or primary ovarian insufficiency) is linked with higher risks of fracture and heart disease. It also notes that hormone therapy is FDA-approved for women whose estrogen is low because of conditions like these or removal of both ovaries.5 This is also the age group where NICE suggests an FSH blood test may be considered.6

Ask about treatment options

Know that there are options. The Menopause Society says hormone therapy is the most effective treatment for hot flashes and night sweats and for vaginal and urinary symptoms. For healthy women under 60, or within 10 years of menopause, without contraindications, it describes the benefit-risk ratio as favorable.5 For women who can't or don't want to use hormones, its 2023 statement gives cognitive behavioral therapy (CBT) its top grade (Level I) for hot flashes.7 For what ACOG's October 2026 menopause guideline says about hormone therapy, non-drug approaches and supplements, see our summary of the guideline.

Something has changed since many of us last looked. In November 2025, the FDA began removing the boxed warnings about heart disease, breast cancer and probable dementia from menopausal hormone therapy labels. The boxed warning about endometrial cancer stays for systemic estrogen-alone products, and information about heart disease and breast cancer risk stays in the labels.8 On February 12, 2026, the FDA approved the first updated labels, for six products, and said 29 companies had submitted proposed changes.9 When we checked the FDA's list on October 22, 2026, it still named those same six.10 Products that aren't on that list may still carry the older label wording. The risks haven't disappeared, and what matters is how they apply to you. If you were told years ago that hormone therapy was off the table, it may be worth asking again.

If you feel brushed off

The Menopause Society encourages women to advocate for themselves. It says you should expect a clinician who listens, makes it comfortable to discuss symptoms, answers your questions and respects your decisions.11 If that isn't happening, it's reasonable to ask for a referral or a second opinion. When choosing someone new, the Society suggests thinking about location, insurance or Medicare, whether they offer telemedicine, and their areas of focus.11 The Society credentials clinicians who pass its competency exam as Menopause Society Certified Practitioners (MSCP), and its website has a search tool to find one.11

Your appointment checklist

Print this page or copy the list into your phone.

  • Two weeks of symptom notes (the tracker works)
  • Date of your last period, and how your cycle has changed
  • Any unusual bleeding: very heavy, between periods, after intimacy, or after menopause
  • Your top three concerns, most important first
  • All medications, vitamins and supplements, with doses
  • Personal and family history: breast cancer, blood clots, stroke, heart disease, liver disease, osteoporosis
  • Contraception, if you still need it
  • Your goals: what would "better" look like for you?
  • Questions about hormone and non-hormone options
  • A pen, or a friend, to write down the plan and the follow-up date

Before you leave

Repeat the plan back in your own words. Ask what to watch for, when you'll review how it's going, and how to reach the office with questions. That's what turns ten minutes into a plan.

What to take to your doctor

  • Your tracker, your top three concerns, and your medication list
  • "Could my symptoms be perimenopause, and what else should we rule out?"
  • "What are my hormone and non-hormone options, given my history?"
  • "Do I need any tests, and why?"
  • "When will we review how this is working?"

Print the two-week tracker

Talk to a menopause-trained provider

Sources

  1. Kling JM, et al. Menopause management knowledge in postgraduate family medicine, internal medicine, and obstetrics and gynecology residents: a cross-sectional survey. Mayo Clin Proc. 2019. PMID 30711122. https://pubmed.ncbi.nlm.nih.gov/30711122/
  2. National Institute on Aging. How To Prepare for a Doctor's Appointment. https://www.nia.nih.gov/health/medical-care-and-appointments/how-prepare-doctors-appointment
  3. ACOG. The Menopause Years (FAQ). https://www.acog.org/womens-health/faqs/the-menopause-years
  4. ACOG. Abnormal Uterine Bleeding (FAQ). https://www.acog.org/womens-health/faqs/abnormal-uterine-bleeding
  5. The Menopause Society. The 2022 hormone therapy position statement. Menopause. 2022. PMID 35797481. https://pubmed.ncbi.nlm.nih.gov/35797481/
  6. NICE. Menopause: identification and management (NG23), Recommendations. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  7. The Menopause Society. The 2023 nonhormone therapy position statement. Menopause. 2023. PMID 37252752. https://pubmed.ncbi.nlm.nih.gov/37252752/
  8. FDA. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies, Nov 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations
  9. FDA. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products, Feb 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products
  10. FDA. Menopausal Hormone Therapies with Updated Prescribing Information (content current as of Feb 12, 2026; checked Oct 22, 2026). https://www.fda.gov/drugs/drug-safety-and-availability/menopausal-hormone-therapies-updated-prescribing-information
  11. The Menopause Society. Choosing a Healthcare Practitioner. https://menopause.org/patient-education/choosing-a-healthcare-practitioner

Information for better conversations, not a diagnosis. We’re not clinicians; we read the research and show our sources. See our disclaimer.